International experts debate the effectiveness of vaccines for COVID and its mutations
In the context that we face today worldwide with the mutations of COVID-19, the University of Tel Aviv (TAU) and Softpower Connection, its representative for Chile, Peru, Mexico, Costa Rica and Panama, held the webinar “Covid -18 vaccine and mutations. Who will win the race?
In the activity, carried out virtually, presented by Dr. Ella Sklan, from the Department of Clinical Microbiology and Immunology, Sacker School of Medicine and Dr. Adi Stern from the Shmunis School of Biomedicine and Cancer Research & amp; Edmond J. Safra of the Center for Bioinformatics. Both full professors of the TAU.
Dr. Ella Sklan made an analysis of the different types of vaccines used in recent years, from hepatisis A and B, through influenza, polio and Ebola, to show the difference and composition of the Sars Covid vaccine- 19. He finalized the characteristics of the vaccines that are currently being administered and their effect on the respiratory system.
For her part, Dr. Adi Stern referred to mutations. He analyzed the two best-known Spike 501 mutations present in the United Kingdom and in African strains, considered the most transmissible, although not necessarily the most virulent in relation to deaths of infected people. He also analyzed the peak mutation 484, present in South Africa, Brazil, and in Japanese strains, a variant that caused Great Britain to close its borders for all the countries of South America and Portugal. He said this could allow the antibodies to escape, but the good news, he said, is that “a two-dose vaccine is very likely to protect against both mutations.”
“This is the global debate and we want to bring it closer to Chile. Today the contagion curve continues to grow exponentially and we have more than 15 people infected with the British strain. While the vaccination processes for older adults begin next week, we must prepare and anticipate the upcoming challenges. For this reason, for us at SPC it is key to transmit these conversations and share the experiences of Israel, a country that has characteristics very similar to those of Chile and whose experience to date has been very positive, ”says Jennyfer. Salvo, CEO of Sotfpower Connections.
Israel occupies the first place in the list of countries that have already managed to supply more doses to their citizens and in first place if the percentage of the inoculated population is taken into account.
So far, it should be noted that in less than three weeks 20% of the inhabitants of that country have already received the first dose of the vaccine, that is, more than two million people (ourworldindata.org).
Considered one of the most innovative countries in the world, Israel is the world’s second largest innovation ecosystem, third in knowledge and technology productivity, and fifth in business sophistication. It has the largest venture capital industry per capita, invests 4.7% of its GDP ($ 247.9 billion) in R&D, and generates more than 1000 technology Start-Ups per year.
For its part, Tel Aviv University is the eighth in the world in innovation and entrepreneurship, the only non-North American university that ranks in the top 15 for MBA programs and has the highest number of founding unicorns per capita.